KPV
Anti-inflammatory tripeptide derived from alpha-MSH with gut healing properties
Clinical Research Score: 3/5 — Supported by promising preclinical anti-inflammatory research as an alpha-MSH fragment, with human evidence still limited.
Categories: Recovery & Repair, Immune Support
What is KPV?
KPV is becoming the go-to peptide for anyone dealing with gut inflammation, and the results people report are striking. Chronic bloating that's lasted years starts to resolve. IBS-like symptoms calm down. Digestive comfort improves in ways that diet changes alone couldn't achieve.
What makes KPV particularly interesting is its specificity for inflammation. It's not a broad immunosuppressant — it targets the specific inflammatory pathways that cause damage in the gut lining and other tissues. People with inflammatory skin conditions also report improvement, as the anti-inflammatory effects work systemically.
The oral form is especially appealing for gut issues, as it can work directly on the intestinal lining where inflammation occurs. Many people combine KPV with BPC-157 for comprehensive gut healing — KPV quiets the inflammation while BPC-157 repairs the tissue damage. Together, they represent one of the most popular gut restoration protocols in the peptide community.
How KPV works
KPV shuts down one of the body's master inflammatory switches — the NF-kB pathway. When this pathway is overactive (as it is in many chronic inflammatory conditions), it drives the production of inflammatory molecules that damage tissue. KPV turns down that signal, reducing the production of pro-inflammatory cytokines and calming overactive immune cells. It's essentially an off switch for excessive, damaging inflammation — without suppressing the immune system's ability to fight actual threats.
Scientific overview
KPV is a tripeptide consisting of lysine-proline-valine, derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH). It possesses potent anti-inflammatory properties and has shown particular promise in treating inflammatory bowel conditions. KPV acts by inhibiting NF-kB activation, reducing pro-inflammatory cytokine production, and modulating immune cell function.
Dosing
- Starting dose: 200 mcg per day
- Common dosage range: 200-500 mcg per day
- Administration: Subcutaneous, Topical
- Half-life: ~2 hours
- Frequency: 1-2x daily